Tiny study measures fetal pain drug levels in womb
NCT ID NCT02962830
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how the pain medicine sufentanil travels from the amniotic sac into the fetus and mother. Eight women who were ending their pregnancy for medical reasons received a small injection of the drug. Researchers measured drug levels in the fetus, mother, and amniotic fluid to better understand fetal pain relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sufentanil
- What this could lead to
- If successful, this could help develop safe pain relief for fetuses during procedures or treatments.
- What could go wrong
- This is a very small, early study in women already ending their pregnancy. It only measures drug levels, not safety or effectiveness for fetal pain relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRENATAL DIAGNOSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Jeanne de Flandres, CHRU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.